• 13 DE
• 14 EN

• 9 Home
• 10 Contact
• 11 Sitemap

• 7 Press
  • 7.1 Press Releases
    • 7.1.1 Company
      • 7.1.1.1 2000
      • 7.1.1.2 2001
      • 7.1.1.3 2002
      • 7.1.1.4 2003
      • 7.1.1.5 2004
      • 7.1.1.6 2005
      • 7.1.1.7 2006
      • 7.1.1.8 2007
      • 7.1.1.9 2008
    • 7.1.2 Health
  • 7.2 Photos & Logos

Memantine about to be introduced throughout Europe

Innovation for Alzheimer patients

Frankfurt am Main, 18.02.2003

The NMDA receptor antagonist Memantine is going to be introduced in many countries in the world for the first time for the treatment of advanced Alzheimer’s dementia. With the introduction of this substance it is the very first time that a proven and effective treatment is available for the treatment of the advanced stages of the commonest form of dementia. Experts from the USA, UK, Germany and Spain have been discussing the substance’s properties at an international symposium in Berlin with 300 physicians from 15 countries.

Related Links

www.auxura.info

For further information please contact:

Dr. Andrea Kreisselmeier
Head of Corporate Communications
Merz Pharma GmbH & Co. KGaA
Eckenheimer Landstrasse 100
60318 Frankfurt am Main
Germany

Phone: +49 - (0)69 / 15 03 - 853
Fax: +49 - (0)69 / 15 03 - 400
E-Mail: andrea.kreisselmeier@merz.de

• 0.1 A-
• 0.2 A
• 0.3 A+
• 0.4 Print

Search

Search

Search

Login for Professionals

Login for Professionals

Merz DocCheck User Password

new user

German Websites

• Alzheimer´s
• Depression
• Dystonia
• Hair Loss
• Hyal-System
• Liver Disease
• Parkinson´s